SHINE Exceeds Heart Walk Fundraising Goal
SHINE Medical Technologies LLC today announced that its team for the Bert Blain Memorial Virtual Heart Walk raised more than $13,000 to support the American Heart Association’s mission of reducing disability and death caused by heart disease and stroke.
NRC Accepts SHINE Application
SHINE Medical Technologies LLC today announced that the U.S. Nuclear Regulatory Commission (NRC) has begun its detailed technical review of SHINE’s application to operate the medical isotope production facility the company is building in Janesville, Wis.
SHINE Creates Therapeutics Division
SHINE Medical Technologies today announced the creation of a new division of the company — SHINE Therapeutics. The establishment of the division enhances the company’s ability to focus on filling critical future needs in the rapidly growing therapeutic isotope market, while continuing to leverage its radioisotope production expertise.
SHINE closes $50-million financing
SHINE Medical Technologies LLC today announced the closing of a $50-million financing with funds managed by Oaktree Capital Management L.P. (“Oaktree”), a leading global investment firm with more than $120 billion under management as of June 30, 2019.
SHINE & Phoenix Combine for World Record
Phoenix and SHINE Achieve New World Record for Strongest Nuclear Fusion Reaction in a Steady-State System. Leading nuclear technology companies collaborating to help turn nuclear weapons into medicine and help a billion patients. Breakthrough has potential to transform medical isotope production, solve a global health care shortage, provide a stepping stone to cleaner, safer, more abundant energy
2020 Student 3D Design Competition
SHINE Medical Technologies LLC, today announced that it is holding its second annual design competition in collaboration with the School District of Janesville. The competition asks students to create a 3D-printed object to be used by SHINE as an employee award of excellence, titled The Illuminator Award.